Genomics Platform Omic is building a world-leading genomic medicine platform in biotechnology with a mission to massively improve healthcare, signaling opportunities to offer partnerships, data analytics services, or collaboration on large-scale genomic studies.

Small to Medium The company operates with 11-50 employees, indicating a lean organization with potential early-stage product needs, flexible procurement cycles, and high responsiveness to pilot programs, trials, or co-development initiatives.

Seattle Presence Located in Seattle but active in a field with broad industry demand, suggesting alignment with regional biotech clusters, university partnerships, and potential access to academic collaborations, grant-driven programs, and talent pipelines.

Digital Maturity Tech stack includes modern web and analytics tools (React, Google Analytics, GTM, HTTP/3, Cloudflare, TrackJS), presenting a receptiveness to cloud-based services, data governance, site reliability, and developer-friendly integrations for platform enhancements.

Investor & M&A Context Recent headlines around Singular Genomics and investor activity imply a dynamic funding and consolidation environment, creating opportunities to offer strategic advisory, integration services, or specialized tools for post-merger integration, security, and compliance.